Coulter & Justus Financial Services’s Gilead Sciences GILD Stock Holding History

Coulter & Justus Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$8.18M	Buy	+111,668	New	+$8.59M	1.82%	24

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coulter & Justus Financial Services's GILD Position: Q1 2024 in Review

Coulter & Justus Financial Services opened a new position in Gilead Sciences (GILD) in Q1 2024: 111,668 shares worth $8.18M. The stake represents 1.82% of the portfolio and ranks #24 among its holdings.

1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

Coulter & Justus Financial Services held 111,668 shares of Gilead Sciences worth $8.18M as of Q1 2024.
Gilead Sciences was a new Coulter & Justus Financial Services position in Q1 2024.
Gilead Sciences made up 1.82% of Coulter & Justus Financial Services's portfolio in Q1 2024, its #24 holding.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Coulter & Justus Financial Services's 13F filing for Q1 2024, filed 3 May 2024.